Pulmonary vascular & cardiac

Hypertension in Pregnancy

Gestational hypertension and pre-eclampsia — exercise, and the long-term cardiovascular signal.

For patients & health professionals
Hypertension A–Z of Conditions · 36 of 86 ICU-Acquired Weakness
Authorship & review
Dr Sean James Ledger, BSc Physio (Hons) MSc PhD FHEA
Director and Principal Physiotherapist
Ahpra registration PHY0002298174
Version
1.0
Last updated
30 August 2026
Next review
30 August 2027
Every guide on this site is reviewed at least once a year, and sooner when the evidence changes.
How these guides are written and reviewed →
Part 1 · In plain language

High blood pressure in pregnancy is common and ranges from mild to serious. Pre-eclampsia is a more severe form affecting the kidneys, liver and blood vessels, and needs close monitoring. Regular moderate exercise during pregnancy is safe for most women and actually reduces the risk of developing it. Importantly, a hypertensive pregnancy is a signal of higher heart and blood vessel risk decades later — which makes long-term follow-up worthwhile.

Our hypertension guide covers the general case. Pregnancy changes both the risk framing and the exercise advice, and it carries a long-term cardiovascular signal that is routinely missed once the pregnancy is over.1

Classification

Definitions follow ISSHP and, in Australia, SOMANZ. Hypertension is generally ≥140/90 mmHg on two occasions; ≥160/110 mmHg is severe and requires urgent treatment.1,2

Pathophysiology

Pre-eclampsia originates in abnormal placentation — inadequate remodelling of spiral arteries producing placental hypoperfusion, with release of anti-angiogenic factors (notably soluble fms-like tyrosine kinase-1) into the maternal circulation. The result is systemic endothelial dysfunction, which explains the multi-organ nature of the disease: hypertension, proteinuria, hepatic and haematological derangement, and cerebral irritability. It is a vascular disease that happens to present in pregnancy.3

Co-morbidities

Hypertensive disorders of pregnancy cluster with the conditions that also predict them, and the overlap is part of why the long-term signal is so strong. Chronic hypertension and chronic kidney disease are both risk factors and consequences. Diabetes — pre-existing and gestational — frequently coexists, as does obesity, which is the most prevalent modifiable factor. Autoimmune disease, particularly antiphospholipid syndrome and lupus, raises risk substantially. Obstructive sleep apnoea is increasingly recognised in pregnancy and is under-diagnosed. ⏹ Relevant to a cardiorespiratory service: peripartum cardiomyopathy and pulmonary oedema both occur more often in hypertensive pregnancy, and pre-eclampsia is associated with venous thromboembolism — see DVT and PE.

Risk factors

Prior pre-eclampsia, chronic hypertension, chronic kidney disease, diabetes, antiphospholipid syndrome, autoimmune disease, obesity, nulliparity, multiple pregnancy, assisted reproduction, maternal age over 40, and family history.

Presentation and monitoring

Frequently asymptomatic and detected on routine antenatal measurement. Warning features include severe headache, visual disturbance, right upper quadrant or epigastric pain, sudden swelling of face and hands, and reduced fetal movements. Severe headache with visual disturbance can herald eclampsia: that combination means contacting the maternity unit now or attending the nearest emergency department, not waiting for an appointment. The remaining features warrant same-day obstetric assessment — a point worth knowing for anyone seeing pregnant women in an outpatient setting.

Management

Antihypertensive therapy with agents safe in pregnancy (labetalol, nifedipine, methyldopa), fetal surveillance, magnesium sulfate for seizure prophylaxis in severe disease, and timing of birth as the definitive treatment. Low-dose aspirin from early pregnancy substantially reduces pre-eclampsia risk in high-risk women and is standard preventive care.4

Medications

Labetalol, nifedipine and methyldopa are the agents used in pregnancy; hydralazine is used acutely. ⛔ ACE inhibitors, ARBs and most statins are contraindicated because of fetal effects, which is a common reason a woman's usual antihypertensive is changed at the first antenatal visit. Magnesium sulfate is given for seizure prophylaxis in severe pre-eclampsia and eclampsia — worth knowing that it causes weakness and reduced reflexes, so a woman on it will not mobilise normally, and that is expected rather than concerning. Low-dose aspirin from early pregnancy is preventive in high-risk women.4 ⚠ For us the practical point is that beta-blockade blunts the heart-rate response on top of pregnancy's own altered physiology, so RPE-based prescription is the only reliable approach.

Multi-system manifestations

Pre-eclampsia is a systemic endothelial disease, not simply high blood pressure, and the multi-organ nature is the reason it is dangerous. Renal involvement produces proteinuria and may progress to acute kidney injury. Hepatic involvement gives epigastric or right upper quadrant pain, deranged transaminases and, in HELLP syndrome, haemolysis with low platelets. Neurological features — headache, visual disturbance, hyperreflexia — precede eclamptic seizures. Haematological derangement includes thrombocytopenia and disseminated intravascular coagulation. Pulmonary oedema is a recognised and directly relevant complication. Uteroplacental dysfunction causes fetal growth restriction and, in the worst case, placental abruption.

Living with it, and afterwards

A hypertensive pregnancy is frightening in a way that general hypertension is not, because the risk is shared with the baby and the timeline is compressed. Frequent monitoring, possible hospital admission and the prospect of early delivery all disrupt an anticipated experience, and a preterm birth adds neonatal-unit stress to physical recovery. Blood pressure often remains raised for weeks postpartum and requires continued treatment, which surprises women who expected delivery to end the problem. Anxiety about future pregnancies is common and warrants a considered answer: recurrence risk is real but most subsequent pregnancies are managed successfully with aspirin and closer surveillance. ⏹ Postnatal depression is more common after a complicated pregnancy.

Prognosis

The immediate outlook is generally good with appropriate care — blood pressure normalises in most women within weeks to a few months of delivery. The long-term picture is the part that gets missed. Women who have had pre-eclampsia carry roughly double the later risk of ischaemic heart disease, stroke and heart failure, with chronic hypertension often developing within a few years.7,8 Risk is highest after early-onset or severe disease, and after recurrent hypertensive pregnancies. Recurrence in a subsequent pregnancy is around 15–20%, higher after severe or early disease. ⚠ Pregnancy is an early cardiovascular stress test, and a failed one identifies women decades before conventional risk scores would — which is exactly why the question belongs in our cardiac rehabilitation intake.

Exercise in pregnancy

The evidence has moved decisively toward activity. Regular moderate exercise during pregnancy reduces the incidence of gestational hypertension and pre-eclampsia, as well as gestational diabetes and excessive weight gain.5,6 Guidance supports around 150 minutes of moderate-intensity activity weekly for women without contraindications, including resistance work.

Prescribing points
  • Established severe pre-eclampsia is a contraindication to exercise training; management is obstetric.
  • Use rating of perceived exertion rather than heart-rate targets — resting heart rate rises in pregnancy and maximal predictions are unreliable.
  • Avoid prolonged supine positioning after the first trimester; avoid contact and fall-risk activity; attend to heat and hydration.
  • Continue rather than start high-intensity work: a previously sedentary woman begins gently.
  • Stop and refer for vaginal bleeding, regular painful contractions, amniotic fluid leakage, dyspnoea before exertion, dizziness, headache, chest pain or calf pain and swelling.

⚠ The long-term signal, and why it belongs in a cardiorespiratory library

A hypertensive pregnancy is a sex-specific cardiovascular risk factor. Women who have had pre-eclampsia carry roughly double the later risk of ischaemic heart disease, stroke and heart failure, with risk of chronic hypertension elevated within a few years of the index pregnancy. Pregnancy functions as an early cardiovascular stress test, and a failed one identifies women decades before conventional risk scores would.7,8

Despite this, obstetric history is rarely taken in cardiac assessment and postpartum cardiovascular follow-up is inconsistent. Asking "did you have high blood pressure in any pregnancy?" is a two-second question that changes risk stratification, and it belongs in our cardiac rehabilitation intake.

Role of the physiotherapist

Prescribe and supervise safe antenatal activity; recognise the warning features above and escalate rather than manage them; support postpartum reconditioning; and — the highest-value contribution — treat a history of hypertensive pregnancy as a genuine indication for lifelong cardiovascular risk management, delivered through the same rehabilitation and blood pressure pathways as any other risk factor.

Warning signs

Call 000 nowA seizure or fit, a collapse, or becoming unresponsive or difficult to rouse. Also call for sudden severe breathlessness, or breathlessness that stops you lying flat, which can mean fluid on the lungs. Do not drive yourself.
Emergency department todayA severe headache together with visual disturbance — flashing lights, blurring or spots. That combination can herald eclampsia, so contact your maternity unit now or attend the nearest emergency department rather than waiting for an appointment.
Same-day medical assessmentPain under the ribs on the right side or in the upper abdomen, sudden swelling of the face and hands, reduced or altered fetal movements, or a home blood-pressure reading at or above the level your maternity team asked you to report.

Part 1 · References

  1. Magee LA, Brown MA, Hall DR, et al. The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis and management recommendations. Pregnancy Hypertens 2022;27:148–169.
  2. Lowe SA, Bowyer L, Lust K, et al. SOMANZ guidelines for the management of hypertensive disorders of pregnancy. Aust N Z J Obstet Gynaecol 2015;55(5):e1–e29.
  3. Rana S, Lemoine E, Granger JP, Karumanchi SA. Preeclampsia: pathophysiology, challenges, and perspectives. Circ Res 2019;124(7):1094–1112.
  4. Rolnik DL, Wright D, Poon LC, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med 2017;377(7):613–622.
  5. Davenport MH, Ruchat SM, Poitras VJ, et al. Prenatal exercise for the prevention of gestational diabetes mellitus and hypertensive disorders of pregnancy. Br J Sports Med 2018;52(21):1367–1375.
  6. Mottola MF, Davenport MH, Ruchat SM, et al. 2019 Canadian guideline for physical activity throughout pregnancy. Br J Sports Med 2018;52(21):1339–1346.
  7. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007;335(7627):974.
  8. Wu P, Haththotuwa R, Kwok CS, et al. Preeclampsia and future cardiovascular health: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes 2017;10(2):e003497.

References are numbered in citation order (Vancouver/BMJ style) and were current at the time of writing. Guidelines are living documents — verify against the latest version before clinical use.

How we treat this at the clinic

We prescribe safe activity during and after pregnancy, and treat a hypertensive pregnancy as the cardiovascular risk marker it is.

Cardiorespiratory Rehabilitation →
Part 2 of 2

Clinical evidence

Part 1 covers the same condition without the technical detail. What follows is the evidence base behind it, written for clinicians — the literature, the reasoning and the gaps.

For clinicians: this summary supports clinical reasoning and is not a protocol. Check current guidelines and local policy before applying it, and read it alongside the key references and guidelines directory.

Framing. Two findings carry this page. Exercise during pregnancy reduces the incidence of gestational hypertension and pre-eclampsia, reversing older advice to rest.1,2 And a hypertensive pregnancy is a sex-specific cardiovascular risk factor — roughly doubling later risk of ischaemic heart disease, stroke and heart failure — that is routinely missed once the pregnancy ends.3,4

Medical management that shapes the session

  • Established severe pre-eclampsia is a contraindication to exercise training. Management is obstetric; our role is recognition and referral.
  • Low-dose aspirin from early pregnancy substantially reduces pre-eclampsia in high-risk women and is standard preventive care.5
  • Antihypertensives safe in pregnancy — labetalol, nifedipine, methyldopa — affect heart-rate response, reinforcing the case for RPE-based prescription.
  • Birth is the definitive treatment, so the exercise episode has a natural endpoint and a postpartum restart.

What physiotherapy achieves

  • Primary prevention. Meta-analysis of prenatal exercise shows reduced odds of gestational hypertension and pre-eclampsia, alongside reduced gestational diabetes and excessive weight gain.1
  • Postpartum reconditioning and a structured pathway into long-term cardiovascular risk management.
  • Risk identification. Asking "did you have high blood pressure in any pregnancy?" takes two seconds and reclassifies risk in a way conventional scores do not capture.

Physiotherapy implications

  • Around 150 minutes of moderate activity weekly, including resistance work, for women without contraindications.2
  • Use RPE, not heart rate. Resting heart rate rises in pregnancy and maximal predictions are unreliable.
  • Avoid prolonged supine positioning after the first trimester; avoid contact and fall-risk activity; attend to heat and hydration.
  • Continue rather than start intensity — a previously sedentary woman begins gently.
  • Stop and refer for vaginal bleeding, regular painful contractions, amniotic fluid leakage, dyspnoea before exertion, dizziness, headache, chest pain, or calf pain and swelling. Epigastric pain or sudden facial and hand swelling warrant same-day obstetric assessment; severe headache with visual disturbance can herald eclampsia and means contacting the maternity unit now or attending the nearest emergency department.

Clinical reasoning

Pregnancy functions as an early cardiovascular stress test, and a failed one identifies women decades before conventional risk scores would. Despite this, obstetric history is rarely taken in cardiac assessment and postpartum cardiovascular follow-up is inconsistent.3,4 The practical implication for a cardiorespiratory service is small and concrete: add the question to the cardiac rehabilitation intake, and treat a positive answer as a genuine indication for lifelong risk management through the same pathways as any other risk factor.

Evidence gaps

  • Optimal exercise dose for pre-eclampsia prevention is not established; trials vary widely in intensity and timing.1
  • Whether postpartum exercise intervention modifies the elevated long-term cardiovascular risk is unstudied.4
  • Exercise evidence in women with established chronic hypertension in pregnancy is sparse.
  • No trial has tested structured cardiovascular follow-up pathways after hypertensive pregnancy despite the consistent epidemiology.3

References for the clinical evidence summary

  1. Davenport MH, Ruchat SM, Poitras VJ, et al. Prenatal exercise for the prevention of gestational diabetes mellitus and hypertensive disorders of pregnancy. Br J Sports Med 2018;52(21):1367–1375.
  2. Mottola MF, Davenport MH, Ruchat SM, et al. 2019 Canadian guideline for physical activity throughout pregnancy. Br J Sports Med 2018;52(21):1339–1346.
  3. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007;335(7627):974.
  4. Wu P, Haththotuwa R, Kwok CS, et al. Preeclampsia and future cardiovascular health: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes 2017;10(2):e003497.
  5. Rolnik DL, Wright D, Poon LC, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med 2017;377(7):613–622.
  6. Magee LA, Brown MA, Hall DR, et al. The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis and management recommendations. Pregnancy Hypertens 2022;27:148–169.
Important: This page is general information, not medical advice. If your breathing or symptoms change suddenly or severely, seek urgent medical care. For personalised assessment, contact Inspire Clinic.

Corrections: If something on this page is wrong, out of date or unclear, we want to know. Email reception@inspireclinic.au with the page name and what you believe is incorrect. Substantive corrections are made promptly, and the guide’s version and last-updated date are changed to reflect it.